{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:54:42Z","timestamp":1790074482024,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Controle do C\u00e2ncer (BR)","award":["CNPq 573806\/2008-0\/FAPERJ E26\/170.026\/2008"],"award-info":[{"award-number":["CNPq 573806\/2008-0\/FAPERJ E26\/170.026\/2008"]}]},{"name":"Programa de Oncobiologia\/Funda\u00e7\u00e3o do C\u00e2ncer"},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (BR)","award":["E-26\/110.375\/2014"],"award-info":[{"award-number":["E-26\/110.375\/2014"]}]},{"DOI":"10.13039\/501100013904","name":"SWISS-BRIDGE Foundation","doi-asserted-by":"crossref","award":["sub-project 1B\/2014"],"award-info":[{"award-number":["sub-project 1B\/2014"]}],"id":[{"id":"10.13039\/501100013904","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00432-017-2575-3","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T06:05:56Z","timestamp":1515477956000},"page":"483-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells"],"prefix":"10.1007","volume":"144","author":[{"given":"Luciano","family":"Mazzoccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Cristina","family":"Robaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Gustavo","family":"Apa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bonamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Wernersbach","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Queiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7672-1088","authenticated-orcid":false,"given":"Claudete Esteves","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"2575_CR1","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.18632\/oncotarget.3805","volume":"6","author":"N Amodio","year":"2015","unstructured":"Amodio N, Rossi M, Raimondi L, Pitari MR, Botta C, Tagliaferri P, Tassone P (2015) miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6:12837\u201312861. https:\/\/doi.org\/10.18632\/oncotarget.3805","journal-title":"Oncotarget"},{"key":"2575_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002","journal-title":"Cell"},{"key":"2575_CR3","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts practical applications. Blood 117:5019\u20135032. https:\/\/doi.org\/10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"key":"2575_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC et al (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43\u201350. https:\/\/doi.org\/10.1038\/ng.2007.30","journal-title":"Nat Genet"},{"key":"2575_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L et al (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393\u2013403. https:\/\/doi.org\/10.1016\/j.molcel.2004.12.030","journal-title":"Mol Cell"},{"key":"2575_CR6","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1038\/onc.2011.60","volume":"30","author":"HH Cheung","year":"2011","unstructured":"Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY (2011) Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30:3404\u20133415. https:\/\/doi.org\/10.1038\/onc.2011.60","journal-title":"Oncogene"},{"key":"2575_CR7","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/sj.onc.1203033","volume":"18","author":"MM Corcoran","year":"1999","unstructured":"Corcoran MM et al (1999) Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 18:6271\u20136277. https:\/\/doi.org\/10.1038\/sj.onc.1203033","journal-title":"Oncogene"},{"key":"2575_CR8","doi-asserted-by":"publisher","first-page":"e0123926","DOI":"10.1371\/journal.pone.0123926","volume":"10","author":"H Cui","year":"2015","unstructured":"Cui H et al (2015) Deregulation between miR-29b\/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer. PLoS One 10:e0123926. https:\/\/doi.org\/10.1371\/journal.pone.0123926","journal-title":"PLoS One"},{"key":"2575_CR9","first-page":"78247827","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824\u20137827","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) MYC on the path to cancer. Cell 149:22\u201335. https:\/\/doi.org\/10.1016\/j.cell.2012.03.003","journal-title":"Cell"},{"key":"2575_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12885-015-1661-7","volume":"15","author":"G Falco De","year":"2015","unstructured":"De Falco G et al (2015) Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. BMC Cancer 15:668. https:\/\/doi.org\/10.1186\/s12885-015-1661-7","journal-title":"BMC Cancer"},{"key":"2575_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cancergen.2014.02.009","volume":"207","author":"N Douet-Guilbert","year":"2014","unstructured":"Douet-Guilbert N et al (2014) Translocation t(2;7)(p11;q21) associated with the CDK6\/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies. Cancer Genet 207:83\u201386. https:\/\/doi.org\/10.1016\/j.cancergen.2014.02.009","journal-title":"Cancer Genet"},{"key":"2575_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149:515\u2013524. https:\/\/doi.org\/10.1016\/j.cell.2012.04.005","journal-title":"Cell"},{"key":"2575_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/embor.2013.20","volume":"14","author":"F Ertel","year":"2013","unstructured":"Ertel F, Nguyen M, Roulston A, Shore GC (2013) Programming cancer cells for high expression levels of Mcl1. EMBO Rep 14:328\u2013336. https:\/\/doi.org\/10.1038\/embor.2013.20","journal-title":"EMBO Rep"},{"key":"2575_CR15","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.4161\/cc.8.15.9168","volume":"8","author":"JM Friedman","year":"2009","unstructured":"Friedman JM, Jones PA, Liang G (2009) The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer. Cell Cycle 8:2313\u20132314. https:\/\/doi.org\/10.4161\/cc.8.15.9168","journal-title":"Cell Cycle"},{"key":"2575_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P et al (2009) c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762\u2013765. https:\/\/doi.org\/10.1038\/nature07823","journal-title":"Nature"},{"issue":"1","key":"2575_CR17","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","volume":"113","author":"R Garzon","year":"2009","unstructured":"Garzon R et al (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT. Blood 113(1):6411\u20136418. https:\/\/doi.org\/10.1182\/blood-2008-07-170589","journal-title":"Blood"},{"key":"2575_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/embor.2009.9","volume":"10","author":"CA Gebeshuber","year":"2009","unstructured":"Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10:400\u2013405. https:\/\/doi.org\/10.1038\/embor.2009.9","journal-title":"EMBO Rep"},{"key":"2575_CR19","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1182\/blood-2012-06-437624","volume":"120","author":"L Giulino-Roth","year":"2012","unstructured":"Giulino-Roth L et al (2012) Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood 120:5181\u20135184. https:\/\/doi.org\/10.1182\/blood-2012-06-437624","journal-title":"Blood"},{"key":"2575_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1084\/jem.20090831","volume":"207","author":"YC Han","year":"2010","unstructured":"Han YC et al (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207:475\u2013489. https:\/\/doi.org\/10.1084\/jem.20090831","journal-title":"J Exp Med"},{"key":"2575_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20009","volume":"40","author":"E Haralambieva","year":"2004","unstructured":"Haralambieva E et al (2004) Interphase fluorescence in situ hybridization for detection of 8q24\/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions. Genes Chromosom Cancer 40:10\u201318. https:\/\/doi.org\/10.1002\/gcc.20009","journal-title":"Genes Chromosom Cancer"},{"key":"2575_CR22","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1038\/oncsis.2013.30","volume":"2","author":"M Hashimoto","year":"2013","unstructured":"Hashimoto M et al (2013) Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo. Oncogenesis 2:e70. https:\/\/doi.org\/10.1038\/oncsis.2013.30","journal-title":"Oncogenesis"},{"key":"2575_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1182\/blood-2003-04-1220","volume":"102","author":"S Hayette","year":"2003","unstructured":"Hayette S et al (2003) In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene. Blood 102:1549\u20131550. https:\/\/doi.org\/10.1182\/blood-2003-04-1220","journal-title":"Blood"},{"key":"2575_CR24","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1073\/pnas.212410199","volume":"99","author":"KK Hoyer","year":"2002","unstructured":"Hoyer KK et al (2002) Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci USA 99:14392\u201314397. https:\/\/doi.org\/10.1073\/pnas.212410199","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR25","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","volume":"121","author":"S Hu","year":"2013","unstructured":"Hu S et al (2013) MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood 121:4021\u20134031. https:\/\/doi.org\/10.1182\/blood-2012-10-460063 (quiz 4250)","journal-title":"Blood"},{"key":"2575_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","volume":"125","author":"J Iqbal","year":"2015","unstructured":"Iqbal J et al (2015) Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood 125:1137\u20131145. https:\/\/doi.org\/10.1182\/blood-2014-04-566778","journal-title":"Blood"},{"key":"2575_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH (2012) MicroRNA cancer. Mol Oncol 6:590\u2013610. https:\/\/doi.org\/10.1016\/j.molonc.2012.09.006","journal-title":"Mol Oncol"},{"key":"2575_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1101\/gad.232009.113","volume":"28","author":"GL Kelly","year":"2014","unstructured":"Kelly GL et al (2014) Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53. Genes Dev 28:58\u201370. https:\/\/doi.org\/10.1101\/gad.232009.113","journal-title":"Genes Dev"},{"key":"2575_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ccell.2016.07.003","volume":"30","author":"K Kollmann","year":"2016","unstructured":"Kollmann K et al (2016) A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 30:359\u2013360. https:\/\/doi.org\/10.1016\/j.ccell.2016.07.003","journal-title":"Cancer Cell"},{"key":"2575_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mrfmmm.2011.03.008","volume":"717","author":"T Kunej","year":"2011","unstructured":"Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA (2011) Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 717:77\u201384. https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.03.008","journal-title":"Mutat Res"},{"key":"2575_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294:853\u2013858. https:\/\/doi.org\/10.1126\/science.1064921","journal-title":"Science"},{"key":"2575_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","volume":"6","author":"J Laine","year":"2000","unstructured":"Laine J, Kunstle G, Obata T, Sha M, Noguchi M (2000) The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 6:395\u2013407","journal-title":"Mol Cell"},{"key":"2575_CR33","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf P et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401\u20131414. https:\/\/doi.org\/10.1016\/j.cell.2007.04.040","journal-title":"Cell"},{"key":"2575_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.2251","volume":"214","author":"U Lehmann","year":"2008","unstructured":"Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17\u201324. https:\/\/doi.org\/10.1002\/path.2251","journal-title":"J Pathol"},{"key":"2575_CR35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2011.354","volume":"31","author":"P Lopez-Serra","year":"2012","unstructured":"Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31:1609\u20131622. https:\/\/doi.org\/10.1038\/onc.2011.354","journal-title":"Oncogene"},{"key":"2575_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.mam.2012.06.005","volume":"34","author":"M Malumbres","year":"2013","unstructured":"Malumbres M (2013) miRNAs and cancer: an epigenetics view. Mol Aspects Med 34:863\u2013874. https:\/\/doi.org\/10.1016\/j.mam.2012.06.005","journal-title":"Mol Aspects Med"},{"key":"2575_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153\u2013166. https:\/\/doi.org\/10.1038\/nrc2602","journal-title":"Nat Rev Cancer"},{"key":"2575_CR38","doi-asserted-by":"publisher","first-page":"14647","DOI":"10.3390\/ijms140714647","volume":"14","author":"S Morita","year":"2013","unstructured":"Morita S, Horii T, Kimura M, Ochiya T, Tajima S, Hatada I (2013) miR-29 represses the activities of DNA methyltransferases and DNA demethylases. Int J Mol Sci 14:14647\u201314658. https:\/\/doi.org\/10.3390\/ijms140714647","journal-title":"Int J Mol Sci"},{"key":"2575_CR39","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","volume":"26","author":"JL Mott","year":"2007","unstructured":"Mott JL, Kobayashi S, Bronk SF, Gores GJ (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133\u20136140. https:\/\/doi.org\/10.1038\/sj.onc.1210436","journal-title":"Oncogene"},{"key":"2575_CR40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/jcb.22630","volume":"110","author":"JL Mott","year":"2010","unstructured":"Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME (2010) Transcriptional suppression of mir-29b-1\/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110:1155\u20131164. https:\/\/doi.org\/10.1002\/jcb.22630","journal-title":"J Cell Biochem"},{"key":"2575_CR41","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1101\/gad.974702","volume":"16","author":"Z Mourelatos","year":"2002","unstructured":"Mourelatos Z et al (2002) miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16:720\u2013728. https:\/\/doi.org\/10.1101\/gad.974702","journal-title":"Genes Dev"},{"key":"2575_CR42","first-page":"2095","volume":"60","author":"MG Narducci","year":"2000","unstructured":"Narducci MG et al (2000) Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res 60:2095\u20132100","journal-title":"Cancer Res"},{"key":"2575_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/onc.2009.19","volume":"28","author":"EJ Noonan","year":"2009","unstructured":"Noonan EJ et al (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28:1714\u20131724. https:\/\/doi.org\/10.1038\/onc.2009.19","journal-title":"Oncogene"},{"key":"2575_CR44","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/cas.12766","volume":"106","author":"LH Oliveira","year":"2015","unstructured":"Oliveira LH et al (2015) Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. Cancer Sci 106:1264\u20131277. https:\/\/doi.org\/10.1111\/cas.12766","journal-title":"Cancer Sci"},{"key":"2575_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nsmb.1533","volume":"16","author":"SY Park","year":"2009","unstructured":"Park SY, Lee JH, Ha M, Nam JW, Kim VN (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16:23\u201329. https:\/\/doi.org\/10.1038\/nsmb.1533","journal-title":"Nat Struct Mol Biol"},{"key":"2575_CR46","doi-asserted-by":"publisher","unstructured":"Poli E, Zhang J, Nwachukwu C, Zheng Y, Adedokun B, Olopade OI, Han YJ (2015) Molecular subtype-specific expression of microRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter. PloS One 10:.e0142224 https:\/\/doi.org\/10.1371\/journal.pone.0142224","DOI":"10.1371\/journal.pone.0142224"},{"key":"2575_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014175","author":"JN Psathas","year":"2014","unstructured":"Psathas JN, Thomas-Tikhonenko A (2014) MYC and the art of microRNA maintenance Cold Spring. Harb Perspect Med 4. https:\/\/doi.org\/10.1101\/cshperspect.a014175","journal-title":"Harb Perspect Med 4"},{"key":"2575_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1309\/AJCP64YOHAWLUMPK","volume":"130","author":"EM Queiroga","year":"2008","unstructured":"Queiroga EM et al (2008) Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Am J Clin Pathol 130:946\u2013956. https:\/\/doi.org\/10.1309\/AJCP64YOHAWLUMPK","journal-title":"Am J Clin Pathol"},{"key":"2575_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.leukres.2014.11.023","volume":"39","author":"MC Robaina","year":"2015","unstructured":"Robaina MC et al (2015a) Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and adolescents with Burkitt lymphoma: biological and clinical implications. Leukemia Res 39:248\u2013256. https:\/\/doi.org\/10.1016\/j.leukres.2014.11.023","journal-title":"Leukemia Res"},{"key":"2575_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yexmp.2015.03.006","volume":"98","author":"MC Robaina","year":"2015","unstructured":"Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM, Klumb CE (2015b) Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. Exp Mol Pathol 98:200\u2013207. https:\/\/doi.org\/10.1016\/j.yexmp.2015.03.006","journal-title":"Exp Mol Pathol"},{"key":"2575_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00277-016-2653-7","volume":"95","author":"MC Robaina","year":"2016","unstructured":"Robaina MC et al (2016) miR-17\u201392 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis. Ann Hematol 95:881\u2013891. https:\/\/doi.org\/10.1007\/s00277-016-2653-7","journal-title":"Ann Hematol"},{"key":"2575_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","volume":"9","author":"Y Saito","year":"2006","unstructured":"Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9:435\u2013443. https:\/\/doi.org\/10.1016\/j.ccr.2006.04.020","journal-title":"Cancer Cell"},{"key":"2575_CR53","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I et al (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123:1187\u20131198. https:\/\/doi.org\/10.1182\/blood-2013-06-507996","journal-title":"Blood"},{"key":"2575_CR54","doi-asserted-by":"publisher","first-page":"12210","DOI":"10.1073\/pnas.1007186107","volume":"107","author":"U Santanam","year":"2010","unstructured":"Santanam U et al (2010) Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci USA 107:12210\u201312215. https:\/\/doi.org\/10.1073\/pnas.1007186107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","volume":"155","author":"JD Schiffman","year":"2011","unstructured":"Schiffman JD et al (2011) Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br J Haematol 155:477\u2013486. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08883.x","journal-title":"Br J Haematol"},{"key":"2575_CR56","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.1073\/pnas.0801130105","volume":"105","author":"S Sengupta","year":"2008","unstructured":"Sengupta S et al (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 105:5874\u20135878. https:\/\/doi.org\/10.1073\/pnas.0801130105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.leu.2401267","volume":"13","author":"J Takizawa","year":"1999","unstructured":"Takizawa J, Seto M (1999) The TCL1 oncogene is not overexpressed in patients with adult T cell leukemia. Leukemia 13:314","journal-title":"Leukemia"},{"key":"2575_CR58","first-page":"712","volume":"89","author":"J Takizawa","year":"1998","unstructured":"Takizawa J et al (1998) Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia Jpn. J Cancer Res 89:712\u2013718","journal-title":"J Cancer Res"},{"key":"2575_CR59","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","volume":"79","author":"R Taub","year":"1982","unstructured":"Taub R et al (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837\u20137841","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1309\/77V7U4E03V69QHRR","volume":"124","author":"MA Teitell","year":"2005","unstructured":"Teitell MA, Lones MA, Perkins SL, Sanger WG, Cairo MS, Said JW (2005) TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma. Am J Clin Pathol 124:569\u2013575. https:\/\/doi.org\/10.1309\/77V7U4E03V69QHRR","journal-title":"Am J Clin Pathol"},{"key":"2575_CR61","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","volume":"68","author":"M Toyota","year":"2008","unstructured":"Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123\u20134132. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0325","journal-title":"Cancer Res"},{"key":"2575_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biocel.2015.05.002","volume":"67","author":"J Tu","year":"2015","unstructured":"Tu J, Liao J, Luk AC, Tang NL, Chan WY, Lee TL (2015) MicroRNAs mediated targeting on the Yin-yang dynamics of DNA methylation in disease and development. Int J Biochem Cell Biol 67:115\u2013120. https:\/\/doi.org\/10.1016\/j.biocel.2015.05.002","journal-title":"Int J Biochem Cell Biol"},{"key":"2575_CR63","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cc.6.9.4209","volume":"6","author":"B Weber","year":"2007","unstructured":"Weber B, Stresemann C, Brueckner B, Lyko F (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6:1001\u20131005. https:\/\/doi.org\/10.4161\/cc.6.9.4209","journal-title":"Cell Cycle"},{"issue":"7","key":"2575_CR64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09779","volume":"471","author":"IE Wertz","year":"2011","unstructured":"Wertz IE et al (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW. Nature 471(7):110\u2013114. https:\/\/doi.org\/10.1038\/nature09779","journal-title":"Nature"},{"key":"2575_CR65","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/hep.23380","volume":"51","author":"Y Xiong","year":"2010","unstructured":"Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51:836\u2013845. https:\/\/doi.org\/10.1002\/hep.23380","journal-title":"Hepatology"},{"key":"2575_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/OTT.S75899","volume":"8","author":"B Yan","year":"2015","unstructured":"Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB, Yang JR (2015) The role of miR-29b in cancer: regulation, function, and signaling. Onco Targets Ther 8:539\u2013548. https:\/\/doi.org\/10.2147\/OTT.S75899","journal-title":"Onco Targets Ther"},{"key":"2575_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47\u201359. https:\/\/doi.org\/10.1038\/nrm2308","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2575_CR68","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","volume":"22","author":"X Zhang","year":"2012","unstructured":"Zhang X et al (2012) Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell 22:506\u2013523. https:\/\/doi.org\/10.1016\/j.ccr.2012.09.003","journal-title":"Cancer Cell"},{"key":"2575_CR69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbrc.2013.06.082","volume":"437","author":"P Zhang","year":"2013","unstructured":"Zhang P, Huang B, Xu X, Sessa WC (2013) Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. Biochem Biophys Res Commun 437:368\u2013373. https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.082","journal-title":"Biochem Biophys Res Commun"},{"key":"2575_CR70","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","volume":"115","author":"JJ Zhao","year":"2010","unstructured":"Zhao JJ et al (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115:2630\u20132639. https:\/\/doi.org\/10.1182\/blood-2009-09-243147","journal-title":"Blood"},{"key":"2575_CR71","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood.V97.12.3902","volume":"97","author":"P Zhou","year":"2001","unstructured":"Zhou P, Levy NB, Xie H, Qian L, Lee CY, Gascoyne RD, Craig RW (2001) MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 97:3902\u20133909","journal-title":"Blood"},{"key":"2575_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13238-016-0277-2","volume":"7","author":"K Zhu","year":"2016","unstructured":"Zhu K et al (2016) MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6. Protein Cell 7:434\u2013444. https:\/\/doi.org\/10.1007\/s13238-016-0277-2","journal-title":"Protein Cell"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2575-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:53:06Z","timestamp":1589835186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2575-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2575"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2575-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}